The crypto market recorded a $2.4 billion surge in Open Interest in December despite a 40% drop in trading activity.The crypto market recorded a $2.4 billion surge in Open Interest in December despite a 40% drop in trading activity.

The crypto market recorded a $2.4 billion surge in Open Interest in December despite a 40% drop in trading activity

2025/12/30 04:20
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Open Interest in cryptocurrencies surged by $2.4 billion in December despite a 40% drop in trading activity in the same month. On-chain data also revealed that Bitcoin and Ethereum futures increased from $35 billion to $38 billion, marking a 7% expansion in leverage, despite market capitulation expectations.

Bitcoin Open Interest increased from $22 billion to $23 billion this month. Ethereum’s Open Interest also added $1.4 billion and surged from $13 billion to $15 billion. CryptoQuant analysts noted that the surge happened while BTC’s price remained near $88,000 and Fear Index registered 37.

Bitcoin registers a Fear Index of 37

On-chain data revealed that Bitcoin added $450 million in fresh leverage in the last 7 days alone. BTC also saw its positions grow 2% weekly. The analytics platform stated that traders opened new positions expecting the price to recover rather than exiting during weakness.

Centralized exchanges, including Binance, OKX, and Bybit, showed steady accumulation through December. CryptoQuant found that every tracked exchange maintained or grew positions rather than clearing risk during this month’s drop.

The analytics platform argued that it contradicts capitulation signals because true bottoms form when leverage clears, but not when it builds. The firm added that a Fear Index of 37, with growing Open Interest, suggests that stubborn optimism persists. 

Data from Coinglass revealed a decline in cumulative Open Interest in futures listed globally from 540,000 BTC to 533,000 BTC. CryptoQuant analysts also believe that markets haven’t reached the despair required for a final washout. 

The firm said this month shows conviction without confirmation, as funding remained positive for traders who were paid for holding long positions. Open Interest also grew as positions opened, but trading activity dropped 40% and whales withdrew 20,000 Bitcoin. The initiatives revealed that professional money exited the market while retail leveraged up.

The other digital assets saw combined weekly outflows of $446 million, which pushed the outflows since October 10 to $3.2 billion. The massive outflows signal weakness in the broader cryptocurrency market sentiment and a slow recovery in the market.

Bitcoin records lower prices 

On-chain data revealed that Bitcoin recorded a total of $443 million in outflows in the last 7 days. The asset’s massive outflows come as its price continues to consolidate below $90,000. At the time of publication, BTC is exchanging hands at around $87,375, down more than 2.2% in the last 7 days.

Crypto analyst Nic Puckrin said on Sunday that Bitcoin has only 3 days left to avoid closing the year in the red. He revealed that BTC only requires more than 6% to end the year positive. The analysts also noted that the asset could break a post-halving performance cycle it has held over a decade if it fails to recover.

Laser Digital analysts noted that Bitcoin tends to underperform during the U.S. timezone. They believe the trend is mostly driven by selling pressure stemming from the year-end tax harvesting flow. John Glover, Chief Investment Officer at Ledn, stated that BTC’s price chart appears promising for higher prices in the future, but there is less certainty in the near term. 

Glover believes the market will trend sideways to slightly lower in the coming weeks or months. He also mentioned that he is looking to add longs between $71,000 and $84,000.

Bitcoin investor Mike Alfred also said on Christmas Day that he was putting his reputation and his BTC holdings on the line for the asset’s future. He promised to sell his entire BTC portfolio if the asset’s price does not reach $1 million by December 31, 2033.

Get $50 free to trade crypto when you sign up to Bybit now

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09